Crown MycoResin Biotech Inc. (CMBI) is a biotechnology-driven company specializing in myco-resin induction technologies for high-value perfumery crops, primarily Aquilaria malaccensis (Agarwood). Through advanced fungal biotechnology, enzyme applications, and microbial inoculants, CMBI enables sustainable resin induction, producing high-grade agarwood and oud oil without relying on destructive harvesting methods.
- Headquarters: Tanza, Cavite, Philippines
- Industry: Biotechnology | Sustainable Forestry | Perfumery Crops
- Core Focus: Myco-induction systems for agarwood resin formation
- Target Market: Agarwood growers, essential oil producers, perfumery industry
I. Company Overview
- Name: Crown MycoResin Biotech Inc. (CMBI)
- Parent Group: Crown Agri Group Inc.
- Subsidiary Focus: Biotech inoculants & resin-induction systems
- Vision: To become the global leader in sustainable myco-resin induction for agarwood and perfumery crops.
- Mission: To develop innovative microbial, enzymatic, and biostimulant solutions that unlock high-value resin production while preserving biodiversity.
II. Products & Services
- Biotic Inoculants
- Fusarium-based spore suspensions
- Proprietary fungal blends inducing agarwood resin
- Dual-Action Resin Induction Systems
- Myco-Enzyme synergistic formulations
- Nano-formulated induction solutions
- Enzymatic Biostimulants
- Laccase & peroxidase-based boosters
- SignalResin™ bio-stimulatory drench
- Consultancy & Training
- Farmer training for agarwood induction
- Resin quality monitoring with GC-MS testing
- Contract Induction Services
- Resin formation outsourcing for plantations
- Inoculation & resin-yield monitoring
III. Market Opportunity
- Global Agarwood Market: USD 14–15 billion (2026 forecast)
- Drivers: Rising demand for natural oud oil, luxury perfumery, sustainable alternatives to wild agarwood.
- Target Clients:
- Agarwood plantation owners (Philippines, Southeast Asia, Middle East)
- Essential oil extractors (CESI and global buyers)
- Perfume brands seeking high-quality oud
IV. Competitive Advantage
- Proprietary Formulations: BarIno™ Biotic & Enzymatic inoculants.
- Integrated Supply Chain: Backed by Crown Agri Group’s plantations, extraction, and trading arms.
- Sustainability: Reduces illegal harvesting pressure by enabling farm-based resin.
- Scientific Rigor: Uses GC-MS profiling for resin quality assurance.
V. Business Model & Revenue Streams
- Product Sales: Biotic inoculants, enzyme boosters, nano-emulsions.
- Service Contracts: Inoculation programs with revenue-sharing.
- Licensing: Technology transfer to international growers.
- Research Partnerships: Universities & fragrance companies.
VI. Operations Plan
- R&D Hub: Lab-based fungal culture and enzyme formulation.
- Production Facility: Fermentation, formulation, and packaging.
- Distribution: Through Crown Agroforestry Plantations Inc. (CAPI) and global networks.
- Quality Control: GC-MS, HPLC, and microbial assays.
VII. Financial Projections (5-Year Outlook)
- Year 1: R&D + pilot sales (~USD 500K revenue)
- Year 3: Expanded production + service contracts (~USD 5M revenue)
- Year 5: Global licensing + exports (~USD 15M revenue)
VIII. Funding Requirements
- Seed Capital: Php 2 million for R&D, lab setup, production facility.
- Growth Capital: Php 5 million for scaling, IP protection, international expansion.
- Investor ROI: 25–30% expected IRR over 5 years.
IX. Exit Strategy
- IPO under Crown Agri Group Inc.
- Acquisition by biotech or perfumery conglomerates.
- Royalty-based licensing model for global scaling.